Gaining Weight on Retatrutide: Causes, Solutions, and When to Seek Help Gaining weight on retatrutide can be alarming, especially given the drug's reputation for significant weight loss in clinical trials
FDA Approval Timeline As of mid-2025, Retatrutide is: Still under investigation in phase 3 clinical trials Expected to complete primary trials by late 2025 Anticipated to receive FDA approval in 2026 Until then, it is available only for research purposes , and should not be used outside of controlled clinical settings without professional supervision
GCGR agonism has been linked to transient increases in heart rate, a variable that must be closely monitored in any experimental model involving Retatrutide
However, like any medication, they may cause side effects in some individuals
If using a travel case, choose one that blocks light